XNAS · MIRA
+1.21% · +$0.0082 · Vol 69.8K
After hours · updated 16:27:30 ET
MIRA Pharmaceuticals, Inc. Common Stock

MIRA Pharmaceuticals, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$0.6832
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
MIRA
MIRA Pharmaceuticals, Inc. Common Stock
Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

65/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is MIRA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading MIRA catalysts
About MIRA Pharmaceuticals, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2023
Employees
2
Country
US

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.6755
Day high
$0.6899
Day low
$0.6379
Previous close
$0.6750
52W high
$1.80
-62.04% from high
52W low
$0.6139
6% of range
Market cap
$28.4M
EPS
$-1.4100
Beta
0.19
Shares out
42M
Volume
69.8K
0.79× rel vol
Avg volume
88.4K
VWAP
$0.6623
Price history computed in-house
1W
-18.82%
1M
-28.45%
3M
-31.68%
1Y
-55.35%
YTD
-54.75%
SMA 50 $0.9323 · below
SMA 200 $1.19 · below
52W position 6%

MIRA overview

Veridion Score
65
5 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around MIRA.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading MIRA Form 4 filings
Public disclosures

Congress activity in MIRA

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for MIRA in the cached public ledger.

Federal contracts

MIRA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for MIRA in this window.
Lobbying spend

MIRA lobbying filings, year to date.

Registered lobbying filings matched to MIRA Pharmaceuticals, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for MIRA in this window.
Loading news for MIRA
Analyst ratings
Sovereign unlock shows live analyst consensus for MIRA.
Options
Sovereign unlock shows live options positioning for MIRA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.